Jones Financial Companies
PMVP icon

Jones Financial Companies’s PMV Pharmaceuticals PMVP Stock Holding History

Jones Financial Companies’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.31K Hold
1,000
– – ﹤0.01% 4278
2025
Q4 		$1.25K Sell
1,000
-16
-2% -$21 ﹤0.01% 3963
2025
Q3 		$1.5K Hold
1,016
– – ﹤0.01% 3782
2025
Q2 		$1.09K Buy
1,016
+16
+2% +$16 ﹤0.01% 3639
2025
Q1 		$1.11K Hold
1,000
– – ﹤0.01% 3376
2024
Q4 		$1.51K Buy
+1,000
New +$1.58K ﹤0.01% 3066

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jones Financial Companies's PMVP Position: Q1 2026 in Review

Jones Financial Companies held its PMV Pharmaceuticals (PMVP) position steady in Q1 2026 at 1,000 shares worth $1.31K. The position accounts for ﹤0.01% of the portfolio, ranked #4278.

Jones Financial Companies first reported a position in PMVP in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.51K in Q4 2024. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Jones Financial Companies held 1,000 shares of PMV Pharmaceuticals worth $1.31K as of Q1 2026.
  • Jones Financial Companies left its PMV Pharmaceuticals share count unchanged in Q1 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4278 holding.
  • Jones Financial Companies first reported a position in PMV Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Jones Financial Companies's PMV Pharmaceuticals position peaked at $1.51K in Q4 2024.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.